Pharmaceutical Executive
Dr. Steven Fox, CEO of Akelos Inc., discusses the challenges of developing new non-opioid medical products as the need intensifies as the crisis worsens.
Alex Neumeister
Advertisement
Articles by Alex Neumeister
Advertisement
Latest Updated Articles
Emerging Biopharma Tackles the Opioid CrisisSeptember 12th 2019
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Enters $202 Million Agreement to Acquire Engage Bio
2
Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report
3
FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates
4
The Evolving Relationship Between FDA and Biotech
5